Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Climb Bio (CLYM) Retained Earnings (2020 - 2026)

Climb Bio filings provide 7 years of Retained Earnings readings, the most recent being -$303.4 million for Q1 2026.

  • Quarterly Retained Earnings fell 106183.92% to -$303.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$303.4 million through Mar 2026, down 106183.92% year-over-year, with the annual reading at -$289.7 million for FY2025, 1259782.61% down from the prior year.
  • Retained Earnings hit -$303.4 million in Q1 2026 for Climb Bio, down from -$289.7 million in the prior quarter.
  • Across five years, Retained Earnings topped out at $286000.0 in Q1 2025 and bottomed at -$303.4 million in Q1 2026.
  • Average Retained Earnings over 5 years is -$111.5 million, with a median of -$52.0 million recorded in 2022.
  • Peak annual rise in Retained Earnings hit 1250.0% in 2024, while the deepest fall reached 2013172.73% in 2024.
  • Climb Bio's Retained Earnings stood at -$120.9 million in 2022, then soared by 100.0% to -$2000.0 in 2023, then surged by 1250.0% to $23000.0 in 2024, then crashed by 1259782.61% to -$289.7 million in 2025, then fell by 4.72% to -$303.4 million in 2026.
  • Per Business Quant, the three most recent readings for CLYM's Retained Earnings are -$303.4 million (Q1 2026), -$289.7 million (Q4 2025), and -$272.2 million (Q3 2025).